Lung cancer screening for workers exposed to harmful substances
Official title: LUng Cancer Screening With Low-dose Computed Tomography in a Population Exposed to Occupational Lung Carcinogens
Run by Centre Hospitalier Intercommunal Creteil · NCT03562052 · Data updated 2026-11-12
This study is testing if low-dose chest CT scans can help find lung cancer early in smokers aged 55 to 74 who have been exposed to harmful substances at work.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 55 Years to 74 Years |
| Sex | All |
| Enrollment | 6000 (estimated) |
| Sponsor | Centre Hospitalier Intercommunal Creteil Academic / other |
| Locations | 8 sites (Bordeaux and 7 other locations) |
| Status | Recruiting |
| Started | July 22, 2021 |
| Main results expected | July 2026 |
| Study ends | July 31, 2031 |
| Registry record updated | July 9, 2024 |
| Trial ID | NCT03562052 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are current or former smokers aged 55 to 74 with significant occupational exposure to known lung carcinogens.
✕Probably not a fit
Patients with a history of lung cancer, serious comorbidities, or those who have not been exposed to occupational carcinogens will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the feasibility of lung cancer screening using low-dose chest CT scans in a high-risk population of smokers aged 55 to 74 who have been exposed to occupational lung carcinogens. It aims to assess the organization of screening activities, the validity of self-administered questionnaires for identifying high-risk individuals, and the effectiveness of lung cancer detection methods. The study will also monitor smoking cessation rates among participants over a two-year period.
Why it matters
Potential benefit: If successful, this study could lead to improved early detection of lung cancer in high-risk workers, potentially saving lives.
How similar studies have gone: Other studies have shown success with lung cancer screening in high-risk populations, indicating that this approach is promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Subjects at high risk of lung cancer: current smokers smoking 30 pack-years or more or ex-smokers smoking 30 pack-years or more and who have quit smoking for less than 15 years and currently or previously occupationally exposed to lung carcinogens. With an algorithm for determination of minimal duration of exposure to occupational carcinogens (according to the type and duration of occupational lung carcinogens) Exclusion Criteria: * Presence of clinical signs of lung cancer * Subjects with a history of lung cancer * Presence of serious short-term life-threatening comorbidities * Absence of occupational exposure to lung carcinogens according to the predefined criteria * Subjects already included in another prospective cohort study * Subjects already assessed by chest CT scan during the previous year * No tobacco exposure or insufficient tobacco exposure or smoking cessation for more than 15 years.
Where it's running
-
Centre Hospitalier Universitaire de Bordeaux
Bordeaux, France Recruiting -
Centre Hospitalier Intercommunal de Créteil
Créteil, France Recruiting -
Université de Bordeaux
Bordeaux, France Active not recruiting -
Centre Hospitalier Universitaire de Brest
Brest, France Not yet recruiting -
Centre Hospitalier Universitaire de Caen
Caen, France Not yet recruiting -
Centre Hospitalier Universitaire de Rennes
Rennes, France Not yet recruiting
Show 2 more locations
-
Centre Hospitalier Universitaire de Rouen
Rouen, France Not yet recruiting -
Hôpital d'Instruction des Armées Sainte-Anne
Toulon, France Not yet recruiting
Study contacts
- Principal investigator: Jean-Claude Pairon, Pr — Centre Hospitalier Interconnmunal de Créteil
- Study coordinator: Jean-Claude Pairon, Pr
- Email: JC.Pairon@chicreteil.fr
- Phone: 157022093
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden
This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.
-
Urine VOC Test to Detect Lung Cancer in Never Smokers
A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.
-
SI-B036 safety test in advanced and metastatic solid tumors
This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.
-
Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment
This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.
-
ENPP1/cGAS and FAP in Solid Tumors in Vietnamese Patients
This Vietnam-based study will test ENPP1, cGAS, and FAP expression in archived tumor samples from Vietnamese adults with solid cancers using immunohistochemistry.
-
Olive oil before lung cancer surgery to see if it lowers chylothorax
This study tests whether drinking 40 mL of extra-virgin olive oil a few hours before lung cancer surgery can reduce chylothorax after tumor removal.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.